DAXXIFY DaxibotulinumtoxinA-lanm
DAXXIFY DaxibotulinumtoxinA-lanm is a Botulinum Toxin product from Revance, listed by Renz Medical for aesthetic product procurement in Pakistan. It is marked for professional use, so suitability and handling should be confirmed by a qualified practitioner.
Sign in with a clinical account to view price.
DAXXIFY DaxibotulinumtoxinA-lanm quick facts
- Brand
- Revance
- Category
- Botulinum Toxin
- Availability
- In stock
- SKU
- CLIN-082
- Access
- Professional use only
Product overview
DAXXIFY is Revance's peptide-formulated daxibotulinumtoxinA-lanm neuromodulator, FDA-approved for temporary improvement of moderate-to-severe glabellar lines. Confirm the supplied strength, local authorization, storage, and IFU.
Key characteristics
- The named product is retained as a professional botulinum-toxin catalog record.
- Product-specific units, formulation, indications, storage, and market authorization must be checked against the supplied IFU.
Product features
- Structured professional procurement information.
- Image provenance and presentation uncertainty are recorded instead of implied.
Composition / ingredients
- DaxibotulinumtoxinA-lanm, a peptide-formulated botulinum toxin type A product.
- FDA labeling includes 50-unit and 100-unit single-dose vials; confirm the supplied presentation.
Professional applications
- Moderate-to-severe glabellar lines where authorised by local labeling.
Presentation
- The image is representative of the named product family where stated and must not be used to infer an unconfirmed variant.
- Confirm vial count, units, diluent or ready-to-use status, accessories, and traceability labels from the supplied market pack.
Safety and handling
- Botulinum toxin units are product-specific and are not interchangeable. Confirm the exact product, strength, reconstitution or ready-to-use status, route, sterility, and local market authorization from the supplied pack and IFU.
- Do not use when the current manufacturer IFU or local labeling excludes the patient, indication, treatment area, or route of use.
- Screen for allergies, neuromuscular disorders, medicines, pregnancy or breastfeeding, active infection, and prior reactions according to the current IFU.
Use and handling
Preparation and administration must follow the exact supplied presentation's current manufacturer IFU. Renz Medical does not publish injection techniques, dosing, or treatment protocols on storefront product pages.
Storage
- Store and transport exactly as stated on the supplied product label and current manufacturer IFU; cold-chain requirements vary by product and market.
- Keep the product in its original packaging, protect it as directed from light, and do not use after the stated expiry date.
Frequently asked questions
What is DAXXIFY DaxibotulinumtoxinA-lanm?
DAXXIFY DaxibotulinumtoxinA-lanm is a Botulinum Toxin product from Revance, listed by Renz Medical for aesthetic product procurement in Pakistan. It is marked for professional use, so suitability and handling should be confirmed by a qualified practitioner.
What is the price of DAXXIFY DaxibotulinumtoxinA-lanm in Pakistan?
Pricing for DAXXIFY DaxibotulinumtoxinA-lanm is available after signing in with a clinical account.
Is DAXXIFY DaxibotulinumtoxinA-lanm currently available?
DAXXIFY DaxibotulinumtoxinA-lanm is currently marked in stock in the Renz Medical catalog. Stock is checked again when an order is reviewed.
Is DAXXIFY DaxibotulinumtoxinA-lanm for professional use?
DAXXIFY DaxibotulinumtoxinA-lanm is marked for professional use. A qualified practitioner should confirm intended use, handling, contraindications and local professional requirements.
Which DAXXIFY DaxibotulinumtoxinA-lanm options are listed?
The currently listed options are 50 U / 100 U single-dose vial; exact pack to confirm. Select an option on the product page to confirm its price and availability.
What should I verify before ordering DAXXIFY DaxibotulinumtoxinA-lanm?
Confirm the Revance product name, SKU, pack or variant, current stock status and manufacturer instructions. On receipt, verify the seal, batch and expiry information before professional use.
Which Revance presentation is listed?
The listing is for DAXXIFY. Renz Medical confirms the 50-unit or 100-unit presentation, market authorization, and storage requirements before dispatch.
Who may order Revance from Renz Medical?
This is a professional-use clinical product. A clinic account and professional verification are required before checkout, and final presentation and availability are confirmed before dispatch.